[6] | S. Loosen, M. F. Schulze-Hagen, P. Bruners, F. Tacke, C. Trautwein, C. K. Kuhl, T. Lüdde, C. Roderburg, "Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies", Cancers, vol. 11, no. 10, 2019, pp. 1503.
|
[5] | J. Holmar, S. de la Puente-Secades, J. Floege, H. Noels, J. Jankowski, S. Orth-Alampour, "Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review", Cells, vol. 9, no. 11, 2020, pp. 2428.
|
[4] | S. H. Loosen, V. van den Bosch, J. Gorgulho, M. Schulze-Hagen, J. Kandler, M. S. Jördens, F. Tacke, C. Loberg, G. Antoch, T. Brümmendorf, U. P. Neumann, C. K. Kuhl, T. Lüdde, C. Roderburg, "Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy", Journal of Clinical Medicine, vol. 10, no. 7, 2021, pp. 1361.
|
[3] | M. F. Schulze-Hagen, C. Roderburg, T. H. Wirtz, M. S. Jördens, L. Bündgens, S. Abu Jhaisha, P. Hohlstein, J. F. Brozat, P. Bruners, C. Loberg, C. K. Kuhl, C. Trautwein, F. Tacke, T. Lüdde, S. H. Loosen, A. Koch, "Decreased Bone Mineral Density Is a Predictor of Poor Survival in Critically Ill Patients", Journal of Clinical Medicine, vol. 10, no. 16, 2021, pp. 3741.
|
[2] | S. Bhargava, E. Merckelbach, H. Noels, A. Vohra, J. Jankowski, "Homeostasis in the Gut Microbiota in Chronic Kidney Disease", Toxins, vol. 14, no. 10, 2022, pp. 648.
|
[1] | J. Soppert, E. F. Brandt, N. M. Heussen, E. Barzakova, L. M. Blank, L. Küpfer, M. W. Hornef, J. Trebicka, J. Jankowski, M. Berres, H. Noels, "Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis", Clinical Gastroenterology and Hepatology, 2022.
|